🔗 Share this article

A shadow market for unapproved weight-loss medications is propelled by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Treatment Gaining Traction Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Followers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and claims of rapid British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.

Some professionals said the popularity for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Response and Material Removal

Based on TikTok, the platform has taken down violative content and prohibited related keywords and query recommendations. The company stated it was committed to keeping the service secure and allocating resources in strengthening compliance measures.

Digital Trading Operations

Research also discovered groups with up to nine thousand participants selling the experimental drug using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of members, populated with images of weight loss, glowing reviews and step-by-step instructions for mixing or administering at home.

Within minutes of joining one group, a vendor posted contact information, where most transactions occur. The seller provided an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, medical conditions or past usage.

Product Information and Pricing

Within these communities, messages show dark colored parcels with postal service stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20mg. When asked how long a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service said it regularly moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering materials they cannot confirm. Even if the science behind this drug is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.

Her team has previously seen individuals harmed by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to potentially significant health risks”.